Today I bought more shares in Novo NordiskThe pharmaceutical giant has suffered significantly in price and today is my most negative position.
Solid companyStrong track record in treating diabetes and chronic diseases.
Diversification: Being exposed to the pharmaceutical market is resilient and Novo Nordisk is always innovating.
Long-term vision: Taking advantage of price fluctuations to lower my average purchase price and improve my long-term profitability.
Investing in solid companies after significant price drops is a forward-thinking strategy. 💡
#Investimentos
#NovoNordisk
#Ações
#Diversificação
#GetQuin
#VisãoDeFuturo
